Navigation Links
Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
Date:8/19/2007

DANVERS, Mass., Aug. 7 /PRNewswire/ -- The results of a pilot study published in the Nutrition Journal (http://www.nutritionj.com) suggest that children with attention deficit hyperactivity disorder (ADHD) can benefit from daily supplementation of high levels of purified fish oils. The eight-week study demonstrated that children who consumed between 8 and 16 grams per day of EPA and DHA (the long chain omega-3 fatty acids found in fish oil) showed significant improvements in their behavior rated by both their parents and the psychiatrist working with them.

The study monitored the ratio of two fatty acids in the blood: arachidonic acid (AA) and eicosapentaenoic acid (EPA). It has been known from previous studies that children with ADHD have a high AA/EPA ratio in the blood compared to control children. The amount of purified fish oil for each child was adjusted until his or her AA/EPA ratio reached ideal levels.

The study found a statistically significant improvement in inattention, hyperactivity, oppositional/defiant behavior and conduct disorders as the AA/EPA ratio in the blood was lowered. The findings were true for children taking their optimal dosage of drugs to manage their ADHD as well for the children who had voluntarily stopped taking their drugs during the study.

"This is an important study as it indicates when adequate levels of fish oil are added to the diet, significant behavioral changes can occur. This study also indicates that the growing epidemic of ADHD may have a strong nutritional component-the lack of sufficient intake of omega-3 fatty acids, such as EPA and DHA," said Dr. Barry Sears, one of the co-authors of the study. "Equally important is that supplementation with high-dose fish oil is synergistic with existing drugs, giving both the physician and parent new dietary approaches toward correcting this growing epidemic in our children."

About ADHD

ADHD is
'/>"/>

SOURCE Zone Labs, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...., May 16 /- Veridex, LLC announced t...orporation of America Holdings,(LabCorp), has comm...prostate cancer. The new assay uses the biological...er, detecting the methylation of the gene,GST-Pi. ...rimarily in,cancer. Veridex is developing the meth...
(Date:5/15/2008)... Confirm Efficacy for Population Most Affected by ...y 16 /-,Bayer HealthCare Ph...,(Nasdaq: ONXX ) today announced that Nexavar(R) ... survival by 47.3 percent (HR=0.68;,p-value=0.014)...ced,hepatocellular carcinoma (HCC), or primary liv...
(Date:5/15/2008)...O, May 15 /- Medivation, In... an ongoing Phase 1-2 clinical,trial of its novel ...sented,in an oral presentation at the 44th America...ng in Chicago., Session title: New Targeted Str... date and time: Monday, June 2 at 11:30 a.m. Centr...
(Date:5/15/2008)...Presented at ASCO Showed Acceptable Tolerability P...and 4 Neuropathy, WOODCLIFF LAKE, N.J., May 15 /P... agent eribulin mesylate (E7389) demonstrated acti...ith locally advanced or metastatic,breast cancer, ...inical,trial. The study also suggests that eribuli...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Media highlights in the March 1 issue of Biophysical Journal 2310 1Sunrise Announces Release Date for Fourth Quarter Preliminary Selected Financial and Operating Data 12666 1Doing Angioplasty Long After Heart Attack Still Worth It Analysis Shows 12661 1Doing Angioplasty Long After Heart Attack Still Worth It Analysis Shows 12661 2Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call 12656 1
(Date:5/16/2008)... Month-long Campaign to Emphasize the Importance... 16 /PRNewswire/ -- National dental insurer United...nth, a collaboration,between Oral Health America a... the importance of oral health to overall health. ...n the United States for the first time,making it ...
(Date:5/16/2008)... , (Washington) Declaring that Primary care medi...D, FACP, president of the American College of Phys...atives of employers and consumers to issue a call ...retain general internists and other primary care p...tate of primary care medicine in the U.S., Dr. Dal...
(Date:5/16/2008)... Live Web Cast Scheduled for May 19 at 10:...re-FirstCall/ - Response Biomedical,Corporation (T...ne Kay,Chief Executive Officer, is scheduled to p...ealthcare Conference on Monday May 19th at 10:15 a...l be available on the Company,s,Web site at, http:...
(Date:5/16/2008)... HARRISBURG, Pa., May 16 /PRNewswire-USNewswi...4, is an opportunity to highlight the dedication,o...re citizens to become,trained EMS volunteers, acco...son., This year,s theme, "EMS: Your Life is Our M...ncy is or when it occurs, EMS is there to provide,...
Breaking Medicine News(10 mins):Health News:United Concordia Dental Celebrates National Smile Month 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:PA Secretary of Health Announces 'Emergency Medical Services Week,' May 18 - 24 2
...ancer known as cutaneous T-cell lymphoma became su...en 1973 and 2002 , according to a report in the Ju...the disease vary by race, sex and geographic area.... certain cells of the lymph system (called T lymph...
...nts undergoing tonsillectomy, or removal of the to...ir sense of taste following the procedure . Toget...the mouth, the sense of taste contributes consider... and drinking and thus plays a major role in the e...
...ding to new research from The University of Arizon... swept across Africa more recently than previously...nkeys shows that an HIV-like virus, simian immunod... those monkeys after the lineage split into four s...
...ability to listen to a phone message in one ear wh...prehend what both are sayingis an important commu...nes, say researchers of the National Institute on ...ers (NIDCD), one of the National Institutes of Hea...
Other Medicine News:Health News:Cutaneous T-cell Lymphoma Shows Steady Increase 2Health News:Patients Undergoing Tonsillectomy Shows No Change of Taste 2Health News:Evolution of HIV from African Greek Monkeys 2Health News:Evolution of HIV from African Greek Monkeys 3Health News:Genes Influence the Ability to Listen Two Things at a Time 2Health News:Genes Influence the Ability to Listen Two Things at a Time 3
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Medicine Products: